Betting big on the Chinese market, Dr Reddy's Laboratories which has plans to launch over 70 products in the East Asian country has started outsourcing manufacture of some of the drugs to local partners, a company official has said. The company which won the tender to market Olanzapine drug in China, is expected to launch it beginning next year, the official said. "As mentioned earlier, we are working towards filing and an eventual launch of over 70 products, across the chosen therapy areas, over the next few years... We have 8-10 products currently available in the market. All our products are marketed either through our Joint Venture, Kushnan Rotam Reddy Pharmaceuticals (KRRP) or through our partners in China," Dr Reddy's spokesperson told in an email reply. The products are manufactured either in the plant owned by KRRP in China, or partners in China, or in India by Dr. Reddy's, the official further said.